Inhibition of DDX5-Mediated G-Quadruplex Unwinding in the β-Catenin 5′-UTR by Magnesium Isoglycyrrhizinate Alleviates Chemotherapy-Induced Intestinal Injury
Open Access
- 1 January 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9
Abstract
Chemotherapy-induced gastrointestinal toxicity, particularly intestinal barrier disruption and diarrhea, is a major dose-limiting adverse effect with unclear mechanisms. Here, we identify magnesium isoglycyrrhizinate (MIG) as a novel therapeutic agent that ameliorates 5-fluorouracil (5-FU)- and irinotecan-induced intestinal injury by enhancing epithelial barrier integrity. Using MIG as a molecular probe, we revealed a pathogenic mechanism underlying chemotherapy-induced barrier damage. Integrated chemoproteomics (limited proteolysis–mass spectrometry and thermal proteome profiling) analyses revealed direct binding of MIG to the RNA helicase DDX5 (DEAD-box helicase 5), whose expression is markedly increased upon 5-FU-induced injury. Mechanistically, DDX5 destabilizes the G-quadruplex (G4) structure in the CTNNB1 (β-catenin) 5′ untranslated region, suppressing β-catenin production and compromising barrier function. Crucially, MIG acts as a novel DDX5 inhibitor that blocks G4 unwinding, thereby restoring β-catenin expression and barrier integrity in a dose-dependent manner. In vivo, MIG outperforms the canonical DDX5 inhibitor supinoxin in mitigating intestinal damage. Taken together, the results of our study not only establish MIG as a promising therapeutic candidate but also delineate the DDX5/ CTNNB1 axis as a targetable pathway for treating chemotherapy-induced barrier dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (82204401)
- National Natural Science Foundation of China (W2523093)
This publication has 47 references indexed in Scilit:
- Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress SyndromeAdvanced Science, 2025
- Allosterically activating SHP2 by oleanolic acid inhibits STAT3–Th17 axis for ameliorating colitisActa Pharmaceutica Sinica B, 2024
- Low‐Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial CellsAdvanced Science, 2024
- Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrierActa Pharmaceutica Sinica B, 2023
- DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasisHepatology, 2021
- IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel diseaseHuman Genetics, 2021
- DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositisActa Pharmaceutica Sinica B, 2021
- N‐glycosylation by N‐acetylglucosaminyltransferase V enhances the interaction of CD147/basigin with integrin β1 and promotes HCC metastasisThe Journal of Pathology, 2018
- A Map of Protein-Metabolite Interactions Reveals Principles of Chemical CommunicationCell, 2018
- CPT-11 (Irinotecan) and 5-Fluorouracil: a Promising Combination for Therapy of Colorectal CancerEuropean Journal of Cancer, 1996